Vanderbilt

Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease
Fierce Biotech
Sun, 11/14/21 - 10:52 pm
CRISPR
gene editing
Vanderbilt
multiple sclerosis
allergies
IBD
AstraZeneca aims to get COVID-19 therapy into clinic in 2 months
Fierce Biotech
Tue, 06/9/20 - 12:24 pm
AstraZeneca
COVID-19
antibodies
Vanderbilt
Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal
Endpoints
Fri, 05/8/20 - 10:43 am
Acadia Pharma
Vanderbilt
Nuplazid
drug development
Alzheimer's disease
Parkinson's Disease
Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach
Endpoints
Wed, 03/11/20 - 04:16 pm
triple-negative breast cancer
Vanderbilt
R&D
Vanderbilt fills an R&D void left by Big Pharma cutbacks
Fierce Biotech
Tue, 01/22/13 - 11:35 am
Vanderbilt
R&D